*
Jackson Walker and a bankruptcy watchdog face tough
choices
after an ex-partner's judicial romance
*
Latham tops rankings as M&A deal value surges
*
Kellogg Hansen, other law firms seek millions in J&J case
By David Thomas
July 10 (Reuters) - (Billable Hours is Reuters' weekly
report on lawyers and money. Please send tips or suggestions to
An ethics scandal that rocked the corporate bankruptcy world
nearly two years ago is ratcheting up again, with pressure
mounting for law firm Jackson Walker and the U.S. Justice
Department's bankruptcy watchdog to reach a deal or go to trial
over efforts to claw back millions of dollars in legal fees from
the firm.
For months, the U.S. Trustee has demanded that Jackson
Walker disgorge $11 million or more in fees that the firm was
awarded by former U.S. Bankruptcy Judge David Jones, whose
romance with one of Jackson Walker's partners threw his Houston
court in turmoil when it became public and the judge resigned
two years ago.
U.S. District Judge Alia Moses in Houston this week gave
Jackson Walker and Kevin Epstein, the U.S. Trustee for the
Southern and Western Districts of Texas, until July 15 to reach
a settlement after weeks of mediation in the trustee's case
against the firm. If they fail at the mediation, which is being
overseen by a retired bankruptcy judge, Moses said she will
schedule the case for trial.
Jackson Walker has acknowledged that it knew by March 2022
that its then-partner Elizabeth Freeman was in a relationship
with Jones but told no one, a federal bankruptcy judge said in
September 2024.
The firm has argued it acted responsibly in its handling of
the relationship. In December 2022, Freeman left the firm. Jones
publicly disclosed the relationship and resigned from the bench
in the fall of 2023.
The trustee objected to fees Jackson Walker earned in at
least 26 cases, arguing that Jones' failure to recuse himself
from any case involving Jackson Walker tainted the fee awards
the firm received from him.
Spokespersons for Jackson Walker and the U.S. Trustee
declined to comment.
Legal experts watching the case say the stakes are high for
both sides, and the settlement could hinge both on the size of
any deal and the trustee's interests in policing the bankruptcy
system.
A purely financial settlement "lets people set the
payment price for a failure to disclose," said Nancy Rapoport, a
law professor at the University of Nevada focused on ethics and
bankruptcy law.
The U.S. Trustee is charged with overseeing the integrity of
the bankruptcy system, said Robert Lawless, a law professor at
the University of Illinois at Urbana-Champaign. A "nominal"
financial settlement could signal that corporate bankruptcy
lawyers play by a different set of rules than everyone else,
Lawless said.
"What happened was very troubling," Lawless said. "From the
U.S. Trustee's perspective, if there's no consequence to this,
it's bad for the system."
A trial on the trustee's claims would be a major event for
the Houston bankruptcy bar, potentially airing internal firm
communications, details about Jones' relationship and returning
scrutiny to the parties' actions in long-closed bankruptcy
cases.
That could be averted even if Tuesday's mediation deadline
passes without a deal, Rapoport noted, since the firm and the
trustee could still hammer out a settlement on their own.
-- Leading U.S. and international law firms jostled for market
share as global M&A activity rose in the first half of the year,
despite uncertainties stemming from U.S. President Donald
Trump's trade war, high interest rates and broader geopolitical
tensions.
The value of global M&A deals announced during the first
half of 2025 hit $1.98 trillion, a 33% increase compared to the
first half of 2024 and the "strongest opening period for deal
making since 2022," the London Stock Exchange Group said in its
rankings of M&A legal advisers released last week.
But the volume of deals has hit a five-year low, LSEG found.
More than 24,000 deals were announced during the first half of
the year, a 10% decline compared to the first half of 2024.
Latham & Watkins, the second highest-grossing U.S. law firm
by revenue, was the top principal adviser on global M&A deals in
LSEG's rankings for the period by deal value, working on 372
global announced deals worth $257 billion. The firm said in a
statement it was grateful to clients for trusting its lawyers on
major deals.
Latham was followed by New York law firm Wachtell Lipton
Rosen & Katz, which served as principal adviser on 55 deals
worth $204 billion. Wachtell's lawyers are "quite busy across a
wide range of industries, and with some large deals in the
pipeline as well," said Andy Nussbaum, the co-chair of
Wachtell's executive committee.
Wachtell served as a legal advisor to U.S. Steel, which was
acquired by Japan's Nippon Steel in a politically sensitive
$14.9 billion deal that closed last month. Nussbaum said in an
email the firm was pleased to see that deal close.
Wachtell and Latham are serving as legal advisers to Charter
Communications and Cox Communications, respectively, for
Charter's $34.5 billion acquisition of the privately held Cox.
The deal is the largest of the year, according to LSEG.
-- Kellogg Hansen and other firms have asked a U.S. judge in
California to award them nearly $20 million in fees after they
prevailed at trial in May against Johnson & Johnson ( JNJ ) subsidiary
Biosense Webster.
Plaintiff Innovative Health in 2019 accused Biosense Webster
of anticompetitive practices focused on clinical services tied
to Biosense's cardiac mapping catheters. Innovative alleged it
was being excluded from the market. The jury awarded damages of
$147 million that were automatically trebled under antitrust law
to more than $442 million.
The 100-lawyer Kellogg Hansen firm jumped into the
litigation last year as lead trial counsel. Kellogg Hansen's
Derek Ho was the firm's highest biller at $1,795 an hour. Ho did
not immediately respond to a request for comment.
Kellogg Hansen, Berger Montague, Theodora Oringher and the
other firms for Innovative said the complexity of the case and
risk of taking it on justified their fee request. Biosense had
denied any wrongdoing. Johnson & Johnson ( JNJ ) did not immediately
respond to a request for comment.
Read more:
Litigation funders get a boost in budget bill drama, court
wins
How much does Hunter Biden's lawyer charge?
Litigation funder fires back at Tyson Foods over settlement
interference claims
Mike Scarcella contributed reporting from Washington. D.C.